Yet contrary to what has been described in other tumors, such as colon cancer [28], we did not observe any clear correlation between percentages of specific immune cells within the tumor and survival, besides for CD163+, which was related to a worse prognosis, although this may be due to its association with the mesenchymal subtype which carries worse prognosis. The gene discussed is CD163; the disease is neoplasm.